Close Menu

NEW YORK (360Dx) – Empire Genomics has signed on Resnova as a distributor for its fluorescent in situ hybridization probes and molecular diagnostic services in Italy, the companies announced today.

In addition to custom, gene-specific, and chromosome control FISH probes, Empire offers a range of cancer genetic testing services for personalized medicine. Specific terms of the deal with Rome-based Resnova were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.